# OnCo record squire (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/squire/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "squire", "NCT00981058" ;
  schema:name "SQUIRE"@en ;
  schema:description "An EGFR antibody added to chemotherapy for squamous lung cancer: it worked, by about six weeks, and almost nobody uses it."@en ;
  schema:url <https://onco.cc/trials/squire/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00981058>, <https://doi.org/10.1016/S1470-2045(15)00021-2> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/lung-squamous-cell-carcinoma/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/necitumumab/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:trials <https://onco.cc/trials/keynote-407/> .
